An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
dc.contributor.author | Sevindik, Omur Gokmen | |
dc.contributor.author | Ozkurt, Zubeyde Nur | |
dc.contributor.author | Boga, Can | |
dc.contributor.author | Besisik, Sevgi Kalayoglu | |
dc.contributor.author | Ipek, Yildiz | |
dc.contributor.author | Geduk, Ayfer | |
dc.contributor.author | Harmandali, Aybuke | |
dc.contributor.author | Salihoglu, Ayse | |
dc.contributor.author | Sahin, Handan Haydaroglu | |
dc.contributor.author | Sonmez, Mehmet | |
dc.contributor.author | Vural, Filiz | |
dc.contributor.author | Akay, Olga Meltem | |
dc.contributor.author | Yuksel, Meltem Kurt | |
dc.contributor.author | Maral, Senem | |
dc.contributor.author | Ekinci, Omer | |
dc.contributor.author | Kirkizlar, Hakki Onur | |
dc.contributor.author | Tekinalp, Atakan | |
dc.contributor.author | Demir, Nazli | |
dc.contributor.author | Merter, Mustafa | |
dc.contributor.author | Saydam, Guray | |
dc.contributor.author | Alacacioglu, Inci | |
dc.contributor.author | Yegin, Zeynep Arzu | |
dc.contributor.author | Kasar, Mutlu | |
dc.contributor.author | Mastanzade, Metban | |
dc.contributor.author | Ozsan, Guner Hayri | |
dc.date.accessioned | 2022-07-07T09:57:44Z | |
dc.date.available | 2022-07-07T09:57:44Z | |
dc.date.issued | 2021 | |
dc.identifier.endpage | S103 | en_US |
dc.identifier.issn | 2152-2650 | en_US |
dc.identifier.startpage | S102 | en_US |
dc.identifier.uri | http://hdl.handle.net/11727/7178 | |
dc.identifier.volume | 21 | en_US |
dc.identifier.wos | 000717640800179 | en_US |
dc.language.iso | eng | en_US |
dc.relation.journal | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy | en_US |
dc.type | conferenceObject | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: